Literature DB >> 17312430

Tachycardia-induced cardiomyopathy: mechanisms of heart failure and clinical implications.

Leonardo Calò1, Ermenegildo De Ruvo, Antonella Sette, Luigi Sciarra, Roberto Scioli, Francesco Sebastiani, Marco Topai, Renzo Iulianella, Giovanna Navone, Ernesto Lioy, Fiorenzo Gaita.   

Abstract

The prognosis of dilated cardiomyopathy is generally poor. The cause of ventricular dysfunction often cannot be identified. In most cases, the clinical history of cardiomyopathy is irreversible but, in some cases, potentially curable causes may be identified. The development of cardiomyopathy may be correlated to atrial or to ventricular arrhythmias. In this scenario, atrial fibrillation is the most frequent cause of ventricular dysfunction, even if it may also be secondary to heart failure. The diagnosis of tachycardia-induced cardiomyopathy can be made only after the improvement of the left ventricular function once the cardiac frequency has slowed down.

Entities:  

Mesh:

Year:  2007        PMID: 17312430     DOI: 10.2459/01.JCM.0000260841.30415.62

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  14 in total

Review 1.  Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies.

Authors:  Mark A Crandall; David J Bradley; Douglas L Packer; Samuel J Asirvatham
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

Review 2.  Should Ablation Be First-Line Therapy for Patients with Paroxysmal AF?

Authors:  Sergio Conti; Atul Verma
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-05

Review 3.  Management of tachyarrhythmias in pregnancy - A review.

Authors:  Priyanka Kugamoorthy; Danna A Spears
Journal:  Obstet Med       Date:  2020-04-20

4.  Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study.

Authors:  Agata Bielecka-Dabrowa; Jan Henryk Goch; Jacek Rysz; Marek Maciejewski; Ravi Desai; Wilbert S Aronow; Maciej Banach
Journal:  Lipids Health Dis       Date:  2010-02-23       Impact factor: 3.876

Review 5.  Tachycardia-mediated cardiomyopathy: recognition and management.

Authors:  Rakesh Gopinathannair; Renee Sullivan; Brian Olshansky
Journal:  Curr Heart Fail Rep       Date:  2009-12

6.  The ECG role in identifying the etiology of tachycardia-induced cardiomyopathy (TIC).

Authors:  M Al Mehairi; S A Al Ghamdi; K Dagriri; A Al Fagih
Journal:  J Saudi Heart Assoc       Date:  2011-12-10

Review 7.  Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management.

Authors:  Rakesh Gopinathannair; Susan P Etheridge; Francis E Marchlinski; Francis G Spinale; Dhanunjaya Lakkireddy; Brian Olshansky
Journal:  J Am Coll Cardiol       Date:  2015-10-13       Impact factor: 24.094

8.  Current Evidence and Recommendations for Rate Control in Atrial Fibrillation.

Authors:  Abhishek Maan; Moussa Mansour; Jeremy N Ruskin; E Kevin Heist
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-04

9.  Surgical treatment of atrial fibrillation: a review.

Authors:  Nadine Hiari
Journal:  Cardiol Res Pract       Date:  2011-06-22       Impact factor: 1.866

Review 10.  Management of tachycardia.

Authors:  Rakesh Gopinathannair; Brian Olshansky
Journal:  F1000Prime Rep       Date:  2015-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.